Ken Griffin Entasis Therapeutics Holdings Inc. Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.45 - $2.27 $14,785 - $23,147
-10,197 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$2.1 - $3.4 $122,591 - $198,481
-58,377 Reduced 85.13%
10,197 $22,000
Q1 2021

May 17, 2021
BUY
$2.01 - $3.53 $29,060 - $51,036
14,458 Added 26.72%
68,574 $147,000
Q4 2020

Feb 16, 2021
BUY
$1.61 - $2.85 $87,126 - $154,230
54,116 New
54,116 $134,000

About Entasis Therapeutics Holdings Inc.

ETTX Quotes by TradingView
  • Ticker ETTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,851,800
  • Market Cap $105M
More about ETTX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email